Synthetic Cannabinoids Global Market Report 2026

Description

Synthetic cannabinoids consist of lab-made chemicals engineered to replicate the actions of natural cannabinoids through attachment to the body's cannabinoid receptors. They arise from sophisticated chemical synthesis processes and often prove far more potent and erratic compared to natural versions. Moreover, certain synthetic cannabinoids find application in controlled pharmaceutical settings for medical treatments.

The primary categories of synthetic cannabinoids consist of high-purity synthetic cannabinoids and ultra-purity synthetic cannabinoids. High-purity synthetic cannabinoids are lab-designed molecules that replicate the actions of natural cannabinoids in cannabis, like tetrahydrocannabinol (THC). They come in diverse forms, including oils, capsules, edibles, vapes, and topicals, targeting uses such as pain relief, nausea and vomiting control, neurological disorder management, and more. Distribution occurs via channels like hospital pharmacies, retail pharmacies, and online pharmacies, serving applications in pharmaceuticals, research, recreational purposes, agriculture, and nutraceuticals.

Tariffs have affected the synthetic cannabinoids market by increasing the cost of imported chemical intermediates, laboratory-grade reagents, and purification equipment. These impacts have been most pronounced in pharmaceutical-grade synthetic cannabinoid segments, particularly in north america and europe where chemical synthesis inputs are globally sourced. Asia-pacific manufacturers have experienced pricing pressures for specialty reagents. However, tariffs have encouraged domestic chemical synthesis capabilities and localized pharmaceutical cannabinoid production.

The synthetic cannabinoids market research report is one of a series of new reports from The Business Research Company that provides synthetic cannabinoids market statistics, including synthetic cannabinoids industry global market size, regional shares, competitors with a synthetic cannabinoids market share, detailed synthetic cannabinoids market segments, market trends and opportunities, and any further data you may need to thrive in the synthetic cannabinoids industry. This synthetic cannabinoids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The synthetic cannabinoids market size has grown rapidly in recent years. It will grow from $2.2 billion in 2025 to $2.59 billion in 2026 at a compound annual growth rate (CAGR) of 17.6%. The growth in the historic period can be attributed to limitations of plant-derived cannabinoids, demand for potency control, pharmaceutical research needs, growth in pain management therapies, regulatory approvals in select regions.

The synthetic cannabinoids market size is expected to see rapid growth in the next few years. It will grow to $4.91 billion in 2030 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to medical cannabis expansion, controlled cannabinoid therapeutics growth, precision dosing demand, synthetic API scalability, pharmaceutical R&D investments. Major trends in the forecast period include expansion of pharmaceutical-grade cannabinoids, growing research use of synthetic cannabinoids, increasing demand for high-purity formulations, shift toward regulated medical applications, advancements in controlled synthesis techniques.

The growing need for treatments for neurological disorders is set to boost the synthetic cannabinoids market in the years ahead. Neurological disorders are conditions affecting the brain, spinal cord, and nerves, impairing movement, sensation, cognition, or general bodily functions. The rising incidence of these disorders stems mainly from an aging worldwide population, with age-related issues like Alzheimer's becoming more prevalent due to brain deterioration and cumulative cellular harm. Synthetic cannabinoids interact with cannabinoid receptors in the brain, modulating neurotransmitter functions and potentially easing symptoms of neurological conditions. For example, in September 2024, the European Brain Council-a Belgium-based health group-reported that 7 million Europeans currently have Alzheimer's disease, a figure projected to double to 14 million by 2030 amid population aging, posing a major global health issue. Thus, the increasing demand for neurological disorder therapies is fueling expansion in the synthetic cannabinoids market.

Major companies in the synthetic cannabinoids market are prioritizing the development of safer, higher-quality products, including novel psychoactive substances, to minimize health risks and enhance their market competitiveness. Novel psychoactive substances are lab-synthesized designer drugs designed to replicate the effects of conventional illegal substances while featuring modified chemical structures to avoid detection and regulation. For example, in December 2023, Quest Diagnostics Inc., a US-based healthcare firm, introduced a new 88-compound Novel Psychoactive Substance (NPS) Test Panel for more precise identification of various synthetic cannabinoids and other designer drugs. This mass-spectrometry-based test offers improved detection of emerging synthetic cannabinoids, enabling healthcare providers to better assess patient exposure and refine treatment strategies. The launch of such sophisticated testing tools underscores the increasing demand for dependable monitoring solutions amid the ongoing evolution of synthetic cannabinoids, promoting greater safety, transparency, and adherence to regulations in the market.

In October 2023, ResolutionRx Ltd, an Australian-based subsidiary of US-based RespireRx Pharmaceuticals Inc., signed a Master Services Agreement with Ab Initio Pharma Pty Ltd. Through this partnership, ResolutionRx seeks to advance its lipid nanoparticle-based dronabinol development program for obstructive sleep apnea, facilitating production for pharmacokinetic, pharmacodynamic, pivotal clinical trials, and eventual commercialization. Ab Initio Pharma Pty Ltd is an Australian-based pharmaceutical manufacturing company.

Major companies operating in the synthetic cannabinoids market are Cayman Chemical, Cerilliant Corporation, Restek Corporation, Chiron AS, BayMedica, CB Therapeutics Inc., Skye Bioscience, Zynerba Pharmaceuticals Inc., Botanix Pharmaceuticals, Kannalife Sciences Inc., SciSparc Ltd., Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd., BioVectra, Noramco Inc., Purisys LLC, Lygos Inc., Johnson Matthey, Almac Group, Cambrex Corporation

North America was the largest region in the synthetic cannabinoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the synthetic cannabinoids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The synthetic cannabinoids market consists of sales of research chemicals, prescription medications, and herbal incense products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Synthetic Cannabinoids Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses synthetic cannabinoids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for synthetic cannabinoids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The synthetic cannabinoids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Product Type: High-Pure Synthetic Cannabinoids; Ultra-Pure Synthetic Cannabinoids
2) By Formulation: Oil; Capsules; Edibles; Vapes; Topicals
3) By Indication: Pain Management; Nausea Or Vomiting; Neurological Disorder Management; Other Indications
4) By Application: Pharmaceuticals; Research; Recreational Use; Agriculture; Nutraceuticals
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids; Research-Grade Cannabinoids; Industrial-Use Cannabinoids
2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids; Biotechnology-Grade Cannabinoids; Analytical-Standard Cannabinoids
Companies Mentioned: Cayman Chemical; Cerilliant Corporation; Restek Corporation; Chiron AS; BayMedica; CB Therapeutics Inc.; Skye Bioscience; Zynerba Pharmaceuticals Inc.; Botanix Pharmaceuticals; Kannalife Sciences Inc.; SciSparc Ltd.; Tetra Bio-Pharma Inc.; Canntab Therapeutics Ltd.; BioVectra; Noramco Inc.; Purisys LLC; Lygos Inc.; Johnson Matthey; Almac Group; Cambrex Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH6MSCAN03_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Synthetic Cannabinoids Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Synthetic Cannabinoids Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Synthetic Cannabinoids Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Synthetic Cannabinoids Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Sustainability, Climate Tech & Circular Economy
- 4.1.3 Industry 4.0 & Intelligent Manufacturing
- 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.5 Artificial Intelligence & Autonomous Intelligence
4.2. Major Trends
- 4.2.1 Expansion Of Pharmaceutical-Grade Cannabinoids
- 4.2.2 Growing Research Use Of Synthetic Cannabinoids
- 4.2.3 Increasing Demand For High-Purity Formulations
- 4.2.4 Shift Toward Regulated Medical Applications
- 4.2.5 Advancements In Controlled Synthesis Techniques

5. Synthetic Cannabinoids Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies
5.2 Research Laboratories
5.3 Hospitals
5.4 Specialty Clinics
5.5 Contract Manufacturing Organizations

6. Synthetic Cannabinoids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Synthetic Cannabinoids Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Synthetic Cannabinoids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Synthetic Cannabinoids Market Size, Comparisons And Growth Rate Analysis
7.3. Global Synthetic Cannabinoids Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Synthetic Cannabinoids Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Synthetic Cannabinoids Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Synthetic Cannabinoids Market Segmentation

9.1. Global Synthetic Cannabinoids Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids
9.2. Global Synthetic Cannabinoids Market, Segmentation By Formulation, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oil, Capsules, Edibles, Vapes, Topicals
9.3. Global Synthetic Cannabinoids Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications
9.4. Global Synthetic Cannabinoids Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals
9.5. Global Synthetic Cannabinoids Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
9.6. Global Synthetic Cannabinoids Market, Sub-Segmentation Of High-Pure Synthetic Cannabinoids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids
9.7. Global Synthetic Cannabinoids Market, Sub-Segmentation Of Ultra-Pure Synthetic Cannabinoids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

10. Synthetic Cannabinoids Market Regional And Country Analysis

10.1. Global Synthetic Cannabinoids Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Synthetic Cannabinoids Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Synthetic Cannabinoids Market

11.1. Asia-Pacific Synthetic Cannabinoids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Synthetic Cannabinoids Market

12.1. China Synthetic Cannabinoids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Synthetic Cannabinoids Market

13.1. India Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Synthetic Cannabinoids Market

14.1. Japan Synthetic Cannabinoids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Synthetic Cannabinoids Market

15.1. Australia Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Synthetic Cannabinoids Market

16.1. Indonesia Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Synthetic Cannabinoids Market

17.1. South Korea Synthetic Cannabinoids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Synthetic Cannabinoids Market

18.1. Taiwan Synthetic Cannabinoids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Synthetic Cannabinoids Market

19.1. South East Asia Synthetic Cannabinoids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Synthetic Cannabinoids Market

20.1. Western Europe Synthetic Cannabinoids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Synthetic Cannabinoids Market

21.1. UK Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Synthetic Cannabinoids Market

22.1. Germany Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Synthetic Cannabinoids Market

23.1. France Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Synthetic Cannabinoids Market

24.1. Italy Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Synthetic Cannabinoids Market

25.1. Spain Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Synthetic Cannabinoids Market

26.1. Eastern Europe Synthetic Cannabinoids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Synthetic Cannabinoids Market

27.1. Russia Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Synthetic Cannabinoids Market

28.1. North America Synthetic Cannabinoids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Synthetic Cannabinoids Market

29.1. USA Synthetic Cannabinoids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Synthetic Cannabinoids Market

30.1. Canada Synthetic Cannabinoids Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Synthetic Cannabinoids Market

31.1. South America Synthetic Cannabinoids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Synthetic Cannabinoids Market

32.1. Brazil Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Synthetic Cannabinoids Market

33.1. Middle East Synthetic Cannabinoids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Synthetic Cannabinoids Market

34.1. Africa Synthetic Cannabinoids Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Synthetic Cannabinoids Market, Segmentation By Product Type, Segmentation By Formulation, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Synthetic Cannabinoids Market Regulatory and Investment Landscape

36. Synthetic Cannabinoids Market Competitive Landscape And Company Profiles

36.1. Synthetic Cannabinoids Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Synthetic Cannabinoids Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Synthetic Cannabinoids Market Company Profiles
- 36.3.1. Cayman Chemical Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Cerilliant Corporation Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Restek Corporation Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Chiron AS Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. BayMedica Overview, Products and Services, Strategy and Financial Analysis

37. Synthetic Cannabinoids Market Other Major And Innovative Companies

CB Therapeutics Inc., Skye Bioscience, Zynerba Pharmaceuticals Inc., Botanix Pharmaceuticals, Kannalife Sciences Inc., SciSparc Ltd., Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd., BioVectra, Noramco Inc., Purisys LLC, Lygos Inc., Johnson Matthey, Almac Group, Cambrex Corporation

38. Global Synthetic Cannabinoids Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Synthetic Cannabinoids Market

40. Synthetic Cannabinoids Market High Potential Countries, Segments and Strategies

40.1 Synthetic Cannabinoids Market In 2030 - Countries Offering Most New Opportunities
40.2 Synthetic Cannabinoids Market In 2030 - Segments Offering Most New Opportunities
40.3 Synthetic Cannabinoids Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer